In Vitro Fertilization (IVF) Market - Global Market Share, Trends, Analysis and Forecasts, 2023 - 2032

Prevalence of infertility disorders, polycystic ovary syndrome (PCOS), lifestyle disorders, and declining cost of IVF procedures are the major parameters shaping the global in vitro fertilization market. Due to changing lifestyle, the infertility rate has increased significantly over last decade.

The prevalence of physiological problems such as the inability of the sperm to penetrate and survive in the cervical mucus, presence of antibodies harming the sperms or eggs, endometriosis, problems associated with uterus or fallopian tubes, poor egg quality, and problems associated with ovulation severely impacts the fertility rate. This has contributed towards the adoption of different type of assisted reproductive technology (ART). The in vitro fertilization has witnessed high adoption owing to the high success rate, and minimal risk as compared to other ARTs. The global in vitro fertilization (IVF) market is anticipated to grow significantly during the forecast period.

Asia Pacific contributed the largest share to the global in-vitro fertilization market in 2019 owing to high infertility rate, prevalence of polycystic ovary syndrome (PCOS), and lifestyle disorders across the region. The Asia Pacific in vitro fertilization market is anticipated to be the fastest growing during forecast period owing to increasing number of dedicated fertility clinics & surgical centers, and growth in fertility tourism in major countries. Europe contributes a significant share to the global in vitro fertilization market and is anticipated to witness steady growth in coming years. North America is anticipated to witness prominent growth during the forecast period owing to rising infertility rate across the region.

The report titled “In Vitro Fertilization (IVF) Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global in vitro fertilization (IVF) market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Thermo Fisher Scientific Inc. reported revenues of USD 24.4 billion in 2018 and the product segment analysis of the company indicates that Laboratory Products & Services business segment of the company dominated revenue in 2018.

The global in vitro fertilization (IVF) market is segmented based on product type, cycle type, end user, and geography. Based on product type, the global in vitro fertilization (IVF) market is segmented into reagents and equipment. The reagents are sub-segmented into embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. The equipment is further sub-segmented into imaging system, sperm separation system, cabinet, ovum aspiration pump, incubators, micro manipulation system, gas analyzer, laser system, accessories, and others. Based on cycle type, the global in vitro fertilization (IVF) market is segmented into fresh non-donor, frozen non-donor, fresh donor, frozen donor. Based on end user, the global in vitro fertilization (IVF) market is segmented into fertility clinics & surgical centers, hospital, research laboratories, and cryobanks. Based on geography, the global in vitro fertilization (IVF) market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on in vitro fertilization (IVF) equipment, reagents and technology. Further, market share of prominent companies in the global in vitro fertilization (IVF) market would also be estimated. For instance, Thermo Fisher Scientific Inc. operates through four business segments namely Life Sciences Solutions, Laboratory Products & Services, Specialty Diagnostics, and Analytical Instruments. The in vitro fertilization (IVF) products are delivered under Laboratory Products & Services business segment of the company with revenue contribution of US$ 9.52 billion in 2018.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the in vitro fertilization (IVF) equipment and reagent manufacturing companies. Furthermore, the global in vitro fertilization (IVF) market study would take into consideration the participants engaged throughout the ecosystem of the market, along with their contribution. Product portfolio would focus on all the products under the in vitro fertilization (IVF) business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global in vitro fertilization (IVF) market.

Major players active in the global in vitro fertilization (IVF) market include Bayer AG, Boston IVF, Cook Medical Incorporated, EMD Serono Inc., Ferring B.V., FUJIFILM Irvine Scientific, Genea Biomedx Pty Ltd, Merck & Co., Inc., OvaScience, Inc., Progyny, Inc., The Cooper Companies, Inc., Thermo Fisher Scientific, and Vitrolife.